Effectiveness and Safety of Ruxolitinib for the Treatment of Refractory Systemic Idiopathic Juvenile Arthritis Like Associated With Interstitial Lung Disease : A Case Report

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2020-216983

Related search